MARC PIERRE-LOUIS: Open Payments
NPI 1457649725 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,096 in 48 payments from 9 companies in 2025. Trend: 2023 $656 · 2024 $893 · 2025 $1,096
Food & beverage: $1,096
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 14 | $326 |
| Janssen Pharmaceuticals, Inc | 9 | $195 |
| Otsuka America Pharmaceutical, Inc. | 6 | $146 |
| Vanda Pharmaceuticals Inc. | 6 | $116 |
| Neurocrine BioSciences, Inc. | 4 | $110 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $73 |
| Alkermes, Inc. | 3 | $62 |
| E.R. Squibb & Sons, L.L.C. | 2 | $50 |
| Lilly USA, LLC | 1 | $18 |
Products named: AUSTEDO XR, INVEGA SUSTENNA, ABILIFY MAINTENA, FANAPT, INGREZZA, UZEDY, CAPLYTA, COBENFY.
Industry payments across FL — which companies pay providers there.
